Analyst Ratings for GlaxoSmithKline (GSK)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/7/2011 | Morgan Stanley | N/A | Upgrade | Equalweight (N/A) |
N/A (N/A) |
44.43 (45.12) |
1.55% | Details |
| 10/31/2011 | Cowen | N/A | Upgrade | Outperform (N/A) |
N/A (N/A) |
44.93 (45.12) |
0.42% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
